1
|
Kulaksız T, Steinbacher J, Kalz M. Technology-Enhanced Learning in the Education of Oncology Medical Professionals: A Systematic Literature Review. JOURNAL OF CANCER EDUCATION : THE OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER EDUCATION 2023; 38:1743-1751. [PMID: 37365373 PMCID: PMC10509048 DOI: 10.1007/s13187-023-02329-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 06/08/2023] [Indexed: 06/28/2023]
Abstract
As cancer continues to be a significant global health challenge, the education of oncology professionals plays a crucial role in providing quality cancer care and achieving optimal patient outcomes. In order to meet the growing need for flexible, accessible, and effective training, this study examines the role of technology-enhanced learning (TEL) in the education of oncology medical professionals. Following the PRISMA guidelines, this systematic review included 34 articles published between 2012 and 2022 in EBSCO and PubMed databases. Findings reveal a diverse range of digital tools being used in oncology training, despite a shortage of advanced educational technologies and limited functional improvement compared to traditional instruction. Since the training primarily targeted at multiple professions in the medical expert role, with radiation oncologists being overrepresented, other oncology domains should be examined more thoroughly in the future, taking into account distinct professional abilities, e.g. communication, collaboration, and leadership skills with reference to the CanMEDS framework. Although the training programmes generally resulted in positive outcomes according to the Kirkpatrick evaluation model, experimental research designs were rather limited. Therefore, the substantial contribution and limitations of TEL in oncology education need to be clarified. Precise reporting of digital tools and instructional processes, as well as challenges encountered, is highly recommended to increase transparency and replicability. Research methodology in digital oncology education remains a major concern and should be addressed accordingly in future research.
Collapse
Affiliation(s)
- Taibe Kulaksız
- Institute for Arts, Music and Media, Heidelberg University of Education, Keplerstraße 87, 69120 Heidelberg, Germany
| | - Jana Steinbacher
- Institute for Arts, Music and Media, Heidelberg University of Education, Keplerstraße 87, 69120 Heidelberg, Germany
| | - Marco Kalz
- Institute for Arts, Music and Media, Heidelberg University of Education, Keplerstraße 87, 69120 Heidelberg, Germany
| |
Collapse
|
2
|
McCombe G, Almaazmi B, Cullen W, Lambert JS, Avramovic G, Murphy C, O'Connor M, Perry N, Ianache I, Lazar S, McHugh T, Surey J, Macías J, Vickerman P, Oprea C. Integrating primary and secondary care to optimize hepatitis C treatment: development and evaluation of a multidisciplinary educational Masterclass series. J Antimicrob Chemother 2020; 74:v24-v30. [PMID: 31782501 PMCID: PMC6883391 DOI: 10.1093/jac/dkz453] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Background It is increasingly being recognized that the elimination of HCV requires a multidisciplinary approach and effective cooperation between primary and secondary care. Objectives As part of a project (HepCare Europe) to integrate primary and secondary care for patients at risk of or infected with HCV, we developed a multidisciplinary educational Masterclass series for healthcare professionals (HCPs) working in primary care in Dublin and Bucharest. This article aims to describe and evaluate the series and examine how this model might be implemented into practice. Methods GPs and other HCPs working in primary care, addiction treatment services and NGOs were invited to eight 1 day symposia (HCV Masterclass series), examining the burden and management of HCV in key populations. Peer-support sessions were also conducted, to give people affected by HCV and community-based organizations working with those directly affected, an update on the latest developments in HCV treatment. Results One hundred percent of participants ‘strongly agreed’ or ‘agreed’ that the Masterclass helped them to appreciate the role of integrated services in ‘the management of patients with HCV’. One hundred percent of participants indicated the importance of a ‘designated nurse to liaise with hospital services’. An improvement of knowledge regarding HCV management of patients with high-risk behaviour was registered at the end of the course. Conclusions Integrated approaches to healthcare and improving the knowledge of HCPs and patients of the latest developments in HCV treatment are very important strategies that can enhance the HCV care pathway and treatment outcomes.
Collapse
Affiliation(s)
| | | | | | - John S Lambert
- UCD School of Medicine, Dublin, Ireland.,Mater Misericordiae University Hospital, Dublin, Ireland
| | | | - Carol Murphy
- Mater Misericordiae University Hospital, Dublin, Ireland
| | | | - Nicola Perry
- Community Response Primary Alcohol and Hepatitis C Service, Dublin, Ireland
| | - Irina Ianache
- Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania
| | - Stefan Lazar
- Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania.,Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| | - Tina McHugh
- Mater Misericordiae University Hospital, Dublin, Ireland
| | - Julian Surey
- Institute of Global Health, University College London, London, UK
| | - Juan Macías
- Infectious Diseases and Microbiology Unit, Hospital Universitario de Valme, Seville, Spain
| | - Peter Vickerman
- School of Social and Community Medicine, University of Bristol, Bristol, UK
| | - Cristiana Oprea
- Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania.,Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
| |
Collapse
|
3
|
Levit LA, Perez RP, Smith DC, Schilsky RL, Hayes DF, Vose JM. Streamlining Adverse Events Reporting in Oncology: An American Society of Clinical Oncology Research Statement. J Clin Oncol 2018; 36:617-623. [DOI: 10.1200/jco.2017.75.8193] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Laura A. Levit
- Laura A. Levit and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Raymond P. Perez, Bristol-Myers Squibb, Lawrence Township, NJ; David C. Smith and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; and Julie M. Vose, University of Nebraska Medical Center, Omaha, NE
| | - Raymond P. Perez
- Laura A. Levit and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Raymond P. Perez, Bristol-Myers Squibb, Lawrence Township, NJ; David C. Smith and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; and Julie M. Vose, University of Nebraska Medical Center, Omaha, NE
| | - David C. Smith
- Laura A. Levit and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Raymond P. Perez, Bristol-Myers Squibb, Lawrence Township, NJ; David C. Smith and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; and Julie M. Vose, University of Nebraska Medical Center, Omaha, NE
| | - Richard L. Schilsky
- Laura A. Levit and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Raymond P. Perez, Bristol-Myers Squibb, Lawrence Township, NJ; David C. Smith and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; and Julie M. Vose, University of Nebraska Medical Center, Omaha, NE
| | - Daniel F. Hayes
- Laura A. Levit and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Raymond P. Perez, Bristol-Myers Squibb, Lawrence Township, NJ; David C. Smith and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; and Julie M. Vose, University of Nebraska Medical Center, Omaha, NE
| | - Julie M. Vose
- Laura A. Levit and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Raymond P. Perez, Bristol-Myers Squibb, Lawrence Township, NJ; David C. Smith and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; and Julie M. Vose, University of Nebraska Medical Center, Omaha, NE
| |
Collapse
|